Using Higher Cut-off Values to Diagnose Acute Myocardial Infarction in Patients With Elevated Hs-cTnT Concentrations
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT06059079 |
Recruitment Status :
Completed
First Posted : September 28, 2023
Last Update Posted : September 28, 2023
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment |
---|---|
Acute Myocardial Infarction | Other: No Intervention |
Acute myocardial infarction (AMI) is a major cause of morbidity and mortality worldwide. In real clinical practice, early and accurate recognition of AMI is crucial to accelerate effective reperfusion therapy. High-sensitivity cardiac troponin T (hs-cTnT) is an important protein that regulates cardiomyocytes excitability, which can be proliferated in cardiomyocytes and released into the blood after myocardial injury or infarction. According to the fourth universal definition of AMI, a rise and/or fall of cTn values with at least one value above the 99th percentile URL is the essential precondition for diagnosing AMI. However, it is challenging for clinicians to diagnose AMI in patients with elevated hs-cTnT levels before a rise and/or fall of hs-cTnT values can be observed, particularly for those who present atypical symptoms and non-significant changes in electrocardiograms (ECG). When the 99th percentile upper reference limit (URL) is referred, it happens frequently that the elevations of hs-cTnT are not caused by AMI, but by other cardiac or even non-cardiac diseases. Therefore, thresholds above the 99th percentile have been proposed to improve the specificity and to accelerate the rule in of myocardial infarction.
This study aimed to find a higher and more accurate cut-off value of hs-cTnT to rule in AMI in a large volume of patients with elevated hs-cTnT.
Study Type : | Observational |
Actual Enrollment : | 80000 participants |
Observational Model: | Cohort |
Time Perspective: | Retrospective |
Official Title: | Using Higher Cut-off Values to Diagnose Acute Myocardial Infarction in Patients With Elevated Hs-cTnT Concentrations |
Actual Study Start Date : | January 1, 2015 |
Actual Primary Completion Date : | May 31, 2023 |
Actual Study Completion Date : | May 31, 2023 |
Group/Cohort | Intervention/treatment |
---|---|
Elevated hs-cTnT group |
Other: No Intervention
No Intervention |
- Number of patients diagnosed with acute myocardial infarction [ Time Frame: Within 3 days of experiencing chest pain, electrocardiogram changes, or abnormal hs-cTnT values. ]
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | Child, Adult, Older Adult |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- Patients hospitalized from January 1,2015 to May 31,2023 in the First Affiliated Hospital of Nanjing Medical University with hs-cTnT concentrations over 14.0 ng/L were enrolled.
Exclusion Criteria:
- Patients who underwent major cardiac surgeries during the hospitalization.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT06059079
China, Jiangsu | |
The First Affiliated Hospital of Nanjing Medical University | |
Nanjing, Jiangsu, China, 210029 |
Responsible Party: | Chunjian Li, Director of Cardiology, The First Affiliated Hospital with Nanjing Medical University |
ClinicalTrials.gov Identifier: | NCT06059079 |
Other Study ID Numbers: |
023 |
First Posted: | September 28, 2023 Key Record Dates |
Last Update Posted: | September 28, 2023 |
Last Verified: | September 2023 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Acute Myocardial Infarction High sensitivity cardiac troponin T Rule in |
Myocardial Infarction Infarction Ischemia Pathologic Processes Necrosis |
Myocardial Ischemia Heart Diseases Cardiovascular Diseases Vascular Diseases |